Literature DB >> 23730023

Acute parvovirus b19 infection leading to severe aplastic anemia in a previously healthy adult female.

Rajesh Rajput1, Ashish Sehgal, Deepak Jain, Rajeev Sen, Abhishek Gupta.   

Abstract

Human Parvovirus B19 has been linked to a variety of diseases. One of the most common complications is transient aplastic crisis in patients with chronic hemolytic anemia. Very few case reports have implicated this virus as a putative etiology behind hepatitis and severe aplastic anemia in immuno competent individuals. We report a case of severe aplastic anemia in a previously healthy adult female due to acute parvovirus B19 infection. Laboratory examination showed pancytopenia in peripheral blood and severe hypoplastic bone marrow on biopsy. Serological analysis (ELISA) revealed acute Parvovirus B19 infection. In the face of unavailable HLA matched bone marrow donor, immuno-supressive therapy was contemplated, but could not be given because of financial constraints. Pancytopenia persists till date, 4 months after the diagnosis, with the patient requiring repeated packed red cell and irradiated platelet transfusions. Thus, acute infection with this virus must be considered a cause of acquired aplastic anemia even in individuals without underlying disease.

Entities:  

Keywords:  Blood Transfusion Medicine; Hematology; Human Genetics; Medicine & Public Health; Oncology

Year:  2011        PMID: 23730023      PMCID: PMC3332267          DOI: 10.1007/s12288-011-0112-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  18 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Human parvovirus induced cytopenias: a report of five cases.

Authors:  P W Saunders; M M Reid; B J Cohen
Journal:  Br J Haematol       Date:  1986-06       Impact factor: 6.998

3.  Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy.

Authors:  M Y Chen; C C Hung; C T Fang; S M Hsieh
Journal:  Clin Infect Dis       Date:  2001-04-10       Impact factor: 9.079

4.  Human parvovirus B19 in patients with aplastic anemia.

Authors:  Baijayantimala Mishra; Pankaj Malhotra; Radha Kanta Ratho; Mini P Singh; Subhash Varma; Neelam Varma
Journal:  Am J Hematol       Date:  2005-06       Impact factor: 10.047

Review 5.  Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease.

Authors:  M Osaki; K Matsubara; T Iwasaki; T Kurata; H Nigami; H Harigaya; K Baba
Journal:  Ann Hematol       Date:  1999-02       Impact factor: 3.673

6.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 7.  Parvovirus-associated arthritis.

Authors:  T L Moore
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

8.  Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.

Authors:  A Srivastava; E Bruno; R Briddell; R Cooper; C Srivastava; K van Besien; R Hoffman
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

9.  A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.

Authors:  Raghad M Al-Abdwani; Faryal A Khamis; Abdullah Balkhair; Mathew Sacharia; Yasser A Wali
Journal:  Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.969

10.  Successful bone marrow transplantation for severe aplastic anemia in a patient with persistent human parvovirus B19 infection.

Authors:  Hiroaki Goto; Amane Ishida; Hisaki Fujii; Fumiko Kuroki; Hiroyuki Takahashi; Koichiro Ikuta; Sumio Kai; Shumpei Yokota
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

View more
  7 in total

1.  Acute parvovirus B19 infection diagnosed by bone marrow biopsy.

Authors:  Sukesh Manthri; Kanishka Chakraborty
Journal:  BMJ Case Rep       Date:  2019-05-06

2.  Acute arrest of hematopoiesis induced by infection with Staphylococcus epidermidis following total knee arthroplasty: A case report and literature review.

Authors:  Lintao Bi; Jun Li; Zhenxia Lu; Hui Shao; Ying Wang
Journal:  Exp Ther Med       Date:  2016-01-25       Impact factor: 2.447

3.  Hereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a Family.

Authors:  Samin Alavi; Nahid Arabi; Mohammad Kaji Yazdi; Mohammad Taghi Arzanian; Farahnaz Zohrehbandian
Journal:  Iran J Med Sci       Date:  2015-09

4.  Preservative Monitoring of a Greek Woman with Hydrops Fetalis due to Parvovirus B19 Infection.

Authors:  Zacharias Fasoulakis; Panagiotis Antsaklis; Emmanuel N Kontomanolis
Journal:  Case Rep Obstet Gynecol       Date:  2017-07-12

5.  Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: A case report.

Authors:  Ayush Mohan Bhattarai; Bishal Dhakal; Pooja Rokaya; Abinash Karki; Shekhar Gurung; Smarika Baral
Journal:  Ann Med Surg (Lond)       Date:  2022-06-15

6.  Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil.

Authors:  Arthur Daniel Rocha Alves; Jéssica Vasques Raposo; Rafaela Moraes Pereira de Sousa; Claudete Aparecida Araújo Cardoso; Pâmela Karla Simões de Freitas Costa; Julienne Martins Araújo; Sabrina Teresinha Alvim Barreiro; Clarisse da Silveira Bressan; Guilherme Amaral Calvet; Rogério Valls de Souza; Patrícia Brasil; Rita de Cássia Nasser Cubel Garcia; Marcelo Alves Pinto; Vanessa Salete de Paula; Luciane Almeida Amado
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

7.  Risk of anaemia in population of healthy young people inhabiting a region in central europe.

Authors:  Małgorzata Szczuko; Izabela Gutowska; Teresa Seidler; Mariusz Mierzwa; Ewa Stachowska; Dariusz Chlubek
Journal:  J Nutr Metab       Date:  2013-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.